Autolus Therapeutics plc (NASDAQ:AUTL) is held by 89 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| MAK CAPITAL ONE LLC | 31 Mar, 2026 | 33,621,487 | 3,616,144 | 12.05% | $46,397,652.00 |
| Blackstone Inc. | 31 Mar, 2026 | 20,485,611 | 0 | 0.00% | $28,270,143.00 |
| Syncona Portfolio Ltd | 31 Mar, 2026 | 16,640,720 | 0 | 0.00% | $22,964,194.00 |
| ARMISTICE CAPITAL, LLC | 31 Mar, 2026 | 15,800,000 | -1,700,000 | -9.71% | $21,804,000.00 |
| Tetragon Partners GP Ltd | 31 Mar, 2026 | 9,500,000 | 0 | 0.00% | $13,110,000.00 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 31 Mar, 2026 | 9,489,345 | 0 | 0.00% | $12,051,468.00 |
| Frazier Life Sciences Management, L.P. | 31 Mar, 2026 | 4,447,910 | -175,414 | -3.79% | $6,138,116.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Mar, 2026 | 3,361,156 | 0 | 0.00% | $4,638,395.00 |
| Laurion Capital Management LP | 31 Mar, 2026 | 3,316,626 | -3,316,626 | -50.00% | $4,576,944.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Mar, 2026 | 2,299,499 | -805,905 | -25.95% | $3,173,309.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 1,844,671 | -116,095 | -5.92% | $2,545,646.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 1,480,732 | -2,205,093 | -59.83% | $2,043,410.00 |
| UBS Group AG | 31 Mar, 2026 | 1,305,779 | 428,679 | 48.87% | $1,801,976.00 |
| Cetera Investment Advisers | 31 Mar, 2026 | 1,129,074 | 29,324 | 2.67% | $1,558,122.00 |
| BALYASNY ASSET MANAGEMENT L.P. | 31 Mar, 2026 | 971,691 | 971,691 | 0.00% | $1,340,934.00 |
| Morgan Stanley | 31 Mar, 2026 | 941,823 | -455,428 | -32.59% | $1,299,716.00 |
| Jpmorgan Chase & Co | 31 Mar, 2026 | 935,403 | -43,872 | -4.48% | $1,187,962.00 |
| Alphabet Inc. | 31 Mar, 2026 | 698,262 | 0 | 0.00% | $963,602.00 |
| Marex Group plc | 31 Mar, 2026 | 542,857 | 542,857 | 0.00% | $749,143.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 459,404 | -700,387 | -60.39% | $633,978.00 |